Cargando…
The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production
A key event in the pathogenesis of Alzheimer’s disease (AD) is the accumulation of amyloid-β (Aβ) species in the brain, derived from the sequential cleavage of the amyloid precursor protein (APP) by β- and γ-secretases. Based on a systems biology study to repurpose drugs for AD, we explore the effec...
Autores principales: | Badiola, Nahuai, Alcalde, Victor, Pujol, Albert, Münter, Lisa-Marie, Multhaup, Gerd, Lleó, Alberto, Coma, Mireia, Soler-López, Montserrat, Aloy, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592824/ https://www.ncbi.nlm.nih.gov/pubmed/23520537 http://dx.doi.org/10.1371/journal.pone.0058837 |
Ejemplares similares
-
Breast Cancer Genes PSMC3IP and EPSTI1 Play a Role in Apoptosis Regulation
por: Capdevila-Busquets, Eva, et al.
Publicado: (2015) -
Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors
por: Yu, Man, et al.
Publicado: (2015) -
The Proton Pump Inhibitor Lansoprazole Improves the Skeletal Phenotype in Dystrophin Deficient mdx Mice
por: Sali, Arpana, et al.
Publicado: (2013) -
Inappropriate proton pump inhibitor lansoprazole prescription in older adults hospitalized in long-term care unit
por: Ladjouzi, Nadia, et al.
Publicado: (2022) -
The proton pump inhibitor, lansoprazole, prevents the development of non-traumatic osteonecrosis of the femoral head: an experimental and prospective clinical trial
por: Kosukegawa, Ima, et al.
Publicado: (2020)